Research
Research
May 28, 2025 • 5 Min
RASolute 302 Trial for KRAS and Other RAS Mutations Recruiting at Multiple Sites
Dr. Hani Babiker is optimistic about the new drug to treat patients with KRAS mutations, now in a phase III trial.
Research
April 23, 2025 • 4 Min
Phase II/III Clinical Trial Recruiting Advanced Pancreatic Cancer Patients
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Research
April 7, 2025 • 5 Min
New Phase III Clinical Trial Actively Recruiting
Dr. Zev Wainberg is enthusiastic about the phase III clinical trial combining a new drug and standard chemo to make immunotherapy more effective.
Research
March 10, 2025 • 3 Min
mRNA Vaccine Shows Sustained Immune Activity in Small Patient Group
Dr. Vinod Balachandran reports notable antitumor response in about half to the patients in his mRNA vaccine clinical trial.
Survivor Stories
Survivor Stories
November 2, 2022 • 3 Min
Urinary Tract Scans Lead to My Diagnosis
Ellen Robbins has the BRCA2 mutation, and that allowed her to participate in a clinical trial for her pancreatic cancer.
Survivor Stories
June 27, 2022 • 4 Min
Taking a Chance on a Clinical Trial
Reesa Levy traveled to find the right pancreatic cancer doctor for her, and then joined a clinical trial for a vaccine.
Survivor Stories
June 1, 2022 • 5 Min
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.
